Squalene: A multi-task link in the crossroads of cancer and aging

Functional Foods in Health and Disease

Volumn 3, Issue 12, 2013, Pages 462-476

  Ronco, Alvaro L ^a,b   de Stéfani, Eduardo ^c  

^a IUCLAEH School of Medicine   (Uruguay)

^b Pereira Rossell Hospital Center   (Uruguay)

^c HOSPITAL DE CLÍNICAS   (Uruguay)

Author keywords

Aging; Antioxidants; Cancer; Cholesterol; Diet; Olive oil; Squalene

Indexed keywords

EID: 84908893418     PISSN: 23787007     EISSN: 21603855     Source Type: Journal    
DOI: 10.31989/ffhd.v3i12.30     Document Type: Review

References (99)

1. Tsujimoto M: A highly unsaturated hydrocarbon in shark liver oil. J Ind Eng Chem 1916, 8(10):889-896.
2. Heilbron IM, Kamm ED, Owens WM: The unsaponifiable matter from the oils of elasmobranch fish. Part I. A contribution to the study of the constitution of squalene (spinacene). J Chem Soc 1926, 1630-1644.
3. Robinson R: Structure of cholesterol. J Soc Chem Ind 1934, 53:1062.
4. Karrer P: Lehrbuch der Organischen Chemie. G.Thieme Verlag, Leipzig, 9th ed. 1943.
5. Das B: The science behind Squalene (The Human Antioxidant). ICBR Publishers, Toronto, 2000.
6. Martirosyan DM, Miroshnichenko LA, Kulakova SN, Pogojeva AV, Zoloedov VI: Amaranth oil application for coronary heart disease and hypertension. Lipids Health Dis 2007, 6:1
7. Owen RW, Mier W, Giacosa A, Hull WE, Spiegelhalder B, Bartsch H: Phenolic compounds and squalene in olive oils: the concentration and antioxidant potential of total phenols, simple phenols, secoiridoids, lignans and squalene. Food Chem Toxicol 2000; 38:647-659.
8. Smith TJ: Squalene: potential chemopreventive agent. Expert Opin Investig Drugs 2000, 9:1841-1848.
9. Kelly GS; Squalene and its potential clinical use. Altern Med Rev 1999, 4(1):2936.
10. MacKenna RMB, Wheatley VR, Wormall A: The composition of surface skin fat (sebum) from the human forearm. J Invest Dermatol 1950, 15:33-47.
11. Liu GC, Ahrens EH, Schreibman PH, Crouse JR: Measurement of squalene in human tissues and plasma: validation and application. J Lipid Res 1976, 17:38-45.
12. Langdon RG, Bloch K: The utilization of squalene in the biosynthesis of cholesterol. J Biol Chem 1953, 200(1):135-144.
13. Ačimovič J, Rozman D: Steroidal triterpenes of cholesterol synthesis. Molecules 2013, 18(4): 4002-4017.
14. Navarro V, Zabala A, Gómez S, Portillo M: Metabolismo del colesterol: bases actualizadas. Rev Esp Obes 2009, 7(6): 360-384.
15. Sharpe LJ, Brown AJ: Controlling cholesterol synthesis beyond 3-hydroxy-3-methylglutaryl-CoA reductase (HMGCR). J Biol Chem 2013, 288(26):18707-18715.
16. Goldstein JL, Brown MS: Progress in understanding the LDL receptor and HMG-CoA reductase, two membrane proteins that regulate the plasma cholesterol. J Lipid Res 1984, 25:1450-1461.
17. Hauß T, Dante S, Dencher NA, Haines TH: Squalane is in the midplane of the lipid bilayer: implications for its function as a proton permeability barrier. Biochim Biophys Acta 2002, 1556(2-3):149-154.
18. Dessi MA, Deiana M, Day BW, Rosa A, Banni S, Corongiu FP: Oxidative stability of polyunsaturated fatty acids: effect of squalene. Eur J Lipid Sci Tech 2002; 104(8): 506-512.
19. Woodward RB, Bloch K: The cyclization of squalene in cholesterol synthesis. J Am Chem Soc 1953, 75:2023.
20. Tchen TT, Bloch K: On the conversion of squalene to lanosterol in vitro. J Biol Chem 1957, 226 (2): 921-930.
21. Christian M: Final report on the safety assessment of squalane and squalene. J Am Coll Toxicol 1982, 1 (2): 37-56.
22. Murkovic M, Lechner S, Pietzka A, Bratacos M, Katzogiannos E: Analysis of minor components in olive oil. J Biochem Biophys Methods 2004, 61 (1-2): 155-60.
23. Sotiroudis TG, Kyrtopoulos SA: Anticarcinogenic compounds of olive oil and related biomarkers. Eur J Nutr 2008, 47 Suppl 2:69-72.
24. Heller JH, Pasternak VZ, Ranson JP, Heller MS: A new reticulo-endothelial stimulating agent from shark livers. Nature (London) 1963, 199:904-905.
25. Warleta F, Ruiz-Mora J, Campos-Segura M, Serrano MJ, Gaforio JJ: El escualeno, componente minoritario del aceite de oliva, y su relación con el cáncer. Aceite de Oliva y Salud, I Congreso de Cultura del Olivo 2007, 765-782. ISBN 978-84-96047-57-0.
26. Newmark HL: Squalene, olive oil, and cancer risk. Review and Hypothesis. In: Cancer Prevention. Novel nutrient and pharmaceutical developments. Ann NY Acad Sci 1999, 889:193-203.
27. Brown MS, Goldstein JL: Multivalent feedback regulation of HMG CoA reductase, a control mechanism coordinating isoprenoid synthesis and cell growth. J Lipid Res 1980, 21(5):505-517.
28. Maltese WA, Sheridan KM: Isoprenoid synthesis during the cell cycle. Studies of 3-hydroxy-3-methylglutaryl-coenzyme A synthase and reductase and isoprenoid labeling in cells synchronized by centrifugal elutriation. J Biol Chem 1988, 263(21):10104-10110.
29. Yano K: Lipid metabolic pathways as lung cancer therapeutic targets: a computational study. Int J Mol Med 2012, 29(4):519-529.
30. Ginestier C, Monville F, Wicinski J, Cabaud O, Cervera N, Josselin E, Finetti P, Guille A, Larderet G, Viens P, Sebti S, Bertucci F, Birnbaum D, Charafe-Jauffret E. Mevalonate metabolism regulates Basal breast cancer stem cells and is a potential therapeutic target. Stem Cells 2012, 30(7):1327-1337.
31. Shi J, Zhu J, Zhao H, Zhong C, Xu Z, Yao F: Mevalonate pathway is a therapeutic target in esophageal squamous cell carcinoma. Tumour Biol 2013, 34(1):429-435.
32. Nilsson S, Huelsenbeck J, Fritz G: Mevalonate pathway inhibitors affect anticancer drug-induced cell death and DNA damage response of human sarcoma cells. Cancer Lett 2011, 304(1):60-69.
33. Khosravi-Far R, Cox AD, Kato K, Der CJ: Protein prenylation: key to ras function and cancer intervention? Cell Growth Differ 1992, 3(7):461-469.
34. Toyokuni S, Okamoto K, Yodoi J, Hiai H: Persistent oxidative stress in cancer. FEBS Letters 1995, 358:1-3.
35. Lasekan JB, Clayton MK, Gendron-Fitzpatrick A, Ney DM: Dietary olive and safflower oils in promotion of DMBA-induced mammary tumorigenesis in rats. Nutr Cancer 1990, 13:153-163.
36. Bartoli R, Fernández-Bañares F, Navarro E, Castellá E, Mañé J, Álvarez M, Pastor C, Cabré E, Gassull MA: Effect of olive oil on early and late events of colon carcinogenesis in rats: modulation of arachidonic acid metabolism and local prostaglandin E(2) synthesis. Gut 2000, 46:191-199.
37. Ichihashi M, Ahmed NU, Budiyanto A, Wu A, Bito T, Ueda M, Osawa T: Preventive effect of antioxidant on ultraviolet-induced skin cancer in mice. J Dermatol Sci 2000, 23:S45-S50.
38. Thuy NT, He P, Takeuchi H: Comparative effect of dietary olive, safflower, and linseed oils on spontaneous liver tumorigenesis in C3H/He mice. J Nutr Sci Vitaminol (Tokyo) 2001, 47:363-366.
39. Van Duuren BL, Goldschmidt BM: Co-carcinogenic and tumor-promoting agents in tobacco carcinogenesis. J Natl Cancer Inst 1976, 56:1237-1242.
40. Murakoshi M, Nishino H, Tokuda H, Iwashima A, Okuzumi J, Kitano H, Iwasaki R: Inhibition by squalene of the tumor-promoting activity of 12-O-tetradecanoylphorbol-13-acetate in mouse-skin carcinogenesis. Int J Cancer 1992, 52: 950-952.
41. Escrich E, Moral R, Grau L, Costa I, Solanas M: Molecular mechanisms of the effects of olive oil and other dietary lipids on cancer. Mol Nutr Food Res 2007, 51(10):1279-1292.
42. Escrich E, Solanas M, Moral R, Costa I, Grau L: Are the olive oil and other dietary lipids related to cancer? Experimental evidence. Clin Transl Oncol 2006, 8(12):868-883.
43. Menendez JA, Lupu R: Mediterranean dietary traditions for the molecular treatment of human cancer: anti-oncogenic actions of the main olive oil's monounsaturated fatty acid oleic acid (18:1n-9). Curr Pharm Biotechnol 2006, 7(6):495-502.
44. Menendez JA, Vazquez-Martin A, Oliveras-Ferraros C, García-Villalba R, Carrasco-Pancorbo A, Fernández-Gutiérrez A, Segura-Carretero A: Analyzing effects of extra-virgin olive oil polyphenols on breast cancer-associated fatty acid synthase protein expression using reverse-phase protein microarrays. Int J Mol Med 2008, 22(4):433-439.
45. Menendez JA, Vazquez-Martin A, Oliveras-Ferraros C, García-Villalba R, Carrasco-Pancorbo A, Fernández-Gutiérrez A, Segura-Carretero A: Extra-virgin olive oil polyphenols inhibit HER2 (erbB-2)-induced malignant transformation in human breast epithelial cells: relationship between the chemical structures of extra-virgin olive oil secoiridoids and lignans and their inhibitory activities on the tyrosine kinase activity of HER2. Int J Oncol 2009, 34(1):43-51.
46. Sánchez-Fidalgo S, Cárdeno A, Sánchez-Hidalgo M, Aparicio-Soto M, Villegas I, Rosillo MA, Alarcón de la Lastra C: Dietary unsaponifiable fraction from extra virgin olive oil supplementation attenuates acute ulcerative colitis in mice. Eur J Pharm Sci 2012, 48(3): 572-581.
47. Sánchez-Fidalgo S, Cárdeno A, Sánchez-Hidalgo M, Aparicio-Soto M, Alarcón de la Lastra C: Dietary extra virgin olive oil polyphenols supplementation modulates DSS-induced chronic colitis in mice. J Nutr Biochem 2013, 24(7): 1401-1413.
48. Rao CV, Newmark HL, Reddy BS: Chemopreventive effect of squalene on colon cancer. Carcinogenesis 1998, 19:287-290.
49. Yamaguchi T, Nakagawa M, Hidaka K, Yoshida T, Akiyama S, Kuwano M: Potentiation by squalene of antitumor effect of 3-[(4-amino-2-methyl-5-pyrimidinyl) methyl]-1-(2chloroethyl)-nitrosourea in a murine tumor system. Jpn J Cancer Res 1985, 76:1021-1026.
50. Smith TJ, Yang GY, Seril DN, Liao J, Kim S: Inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis by dietary olive oil and squalene. Carcinogenesis 1998, 19:703-706.
51. Smith TJ, Kim S, Lee MJ, Yang GY, Newmark HL, Yang CS: Inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NKK)-induced lung tumorigenesis and DNA oxidation by dietary squalene. Proc Am Assoc Cancer Res 1999, 40: 262.
52. Gapor MT, Hazrina AR: Squalene in oils and fats. Palm Oil Developments 2000, 32: 36-40. Katdare M, Singhal H, Newmark H, Osborne MP, Telang NT: Prevention of mammary preneoplastic transformation by naturally-occurring tumor inhibitors. Cancer Lett 1997, 111:141-147.
53. Ohkuma T, Otagiri K, Tanaka S, Ikekawa T: Intensification of host's immunity by squalene in sarcoma 180 bearing ICR mice. J Pharmacobiodyn 1983, 6:148-151.
54. Storm HM, Oh SY, Kimler BF, Norton S: Radioprotection of mice by dietary squalene. Lipids 1993, 28:555-559.
55. Narayan BH, Tatewaki N, Giridharan VV, Nishida H, Konishi T: Modulation of doxorubicin-induced genotoxicity by squalene in Balb/c mice. Food Funct 2010, 1(2):174-179.
56. Das B, Antoon R, Tsuchida R, Lotfi S, Morozova O, Farhat W, Malkin D, Koren G, Yeger H, Baruchel S: Squalene selectively protects mouse bone marrow progenitors against cisplatin and carboplatin-induced cytotoxicity in vivo without protecting tumor growth. Neoplasia 2008, 10(10):1105-1119.
57. Das B, Yeger H, Baruchel H, Freedman MH, Koren G, Baruchel S: In vitro cytoprotective activity of squalene on a bone marrow versus neuroblastoma model of cisplatin-induced toxicity: implications in cancer chemotherapy. Eur J Cancer 2003, 39:2556-2565.
58. Nakagawa M, Yamaguchi T, Fukawa H, Ogata J, Komiyama S, Akiyama S, Kuwano M: Potentiation by squalene of the cytoxicity of anticancer agents against cultured mammalian cells and murine tumor. Jpn J Cancer Res 1985, 76:315-320.
59. Desai KN, Wei H, Lamartiniere CA: The preventive and therapeutic potential of squalene containing compounds on tumour promotion and regression. Cancer Lett 1996, 101:93-96.
60. Schwartz B, Birk Y, Raz A, Madar Z: Nutritional-pharmacological combinations-a novel approach to reducing colon cancer incidence. Eur J Nutr 2004, 43(4):221-229.
61. Ronco AL, De Stéfani E (eds): Nutritional Epidemiology of Breast Cancer. 1st Ed, Springer Publishers, Dordrecht 2012.
62. Calorini L, Peppicelli S, Bianchini F: Extracellular acidity as favouring factor of tumor progression and metastatic dissemination. Exp Oncol 2012, 34(2):79-84.
63. McCarty MF, Whitaker J: Manipulating tumor acidification as a cancer treatment strategy. Altern Med Rev 2010, 15(3):264-272.
64. Robey IF: Examining the relationship between diet-induced acidosis and cancer. Nutrition & Metabolism 2012, 9:72.
65. Richter E, Fichtl B, Schafer SG: Effects of dietary paraffin, squalane and sucrose polyester on residue disposition and elimination of hexachlorobenzene in rats. Chem Biol Interact 1982, 40:335-344.
66. Richter E, Schafer SG: Effect of squalane on hexachlorobenzene (HCB) concentrations in tissues of mice. J Environ Sci Health B 1982, 17:195-203.
67. Kamimura H, Koga N, Oguri K, Yoshimura H: Enhanced elimination of theophylline, phenobarbital and strychnine from the bodies of rats and mice by squalane treatment. J Pharmacobiodyn 1992, 15:215-221.
68. Kalogeropoulos N, Chiou A, Gavala E, Christea M, Andrikopoulos NK: Nutritional evaluation and bioactive microconstituents (carotenoids, tocopherols,sterols and squalene) of raw and roasted chicken fed on DHA-rich microalgae. Food Res Int 2010; 43: 2006-13.
69. Queirolo E, Morales MG, Iacopino A: Tratamiento con Semo-Squalene en la intoxicación crónica por plomo en niños. XV Congreso Argentino de Toxicología, Neuquén, Argentina. Acta Toxicol Argentina 2007, [Abstract] P78:p53.
70. World Health Organization: http://www.who.int/topics/ageing/es/ [Accessed 05-06-2013]
71. Sohal RS, Orr WC: The redox hypothesis of aging. Free Radic Biol Med 2012, 52(3):539-555.
72. Kregel KC, Zhang HJ: An integrated view of oxidative stress in aging: basic mechanisms, functional effects, and pathological considerations. Am J Physiol Regul Integr Comp Physiol 2007, 292(1):R18-36.
73. Cutler RG: Oxidative stress profiling: part I. Its potential importance in the optimization of human health. Ann N Y Acad Sci 2005, 1055:93-135.
74. Finkel T, Holbrook NJ: Oxidants, oxidative stress and the biology of ageing. Nature 2000, 408(6809):239-247.
75. Valko M, Leibfritz D, Moncol J, Cronin MTD, Mazur M, Telser J: Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 2007, 39(1):44-84.
76. Owuor ED, Kong AN: Antioxidants and oxidants regulated signal transduction pathways. Biochem Pharmacol 2002, 64(5-6):765-770.
77. Katan MB, Zock PL, Mensink RP: Dietary oils, serum lipoproteins, and coronary heart disease. Am J Clin Nutr 1995, 61:1368S-1373S.
78. Willett WC, Sacks F, Trichopoulou A, Drescher G, Ferro-Luzzi A, Helsing E, Trichopoulos D: Mediterranean diet pyramid: a cultural model for healthy eating. Am J Clin Nutr 1995, 61 (Suppl.6):1402S-1406S.
79. Ortega RM: Importance of functional foods in the Mediterranean diet. Public Health Nutr 2006, 9 (8A):1136-1140.
80. López-Miranda J, Pérez-Jiménez F, Ros E, De Caterina R, Badimón L, Covas MI, Escrich E, Ordovás JM, Soriguer F, Abiá R, Alarcón de la Lastra C, Battino M, Corella D, Chamorro-Quirós J, Delgado-Lista J, Giugliano D, Esposito K, Estruch R, Fernández-Real JM, Gaforio JJ, La Vecchia C, Lairon D, López-Segura F, Mata P, Menéndez JA, Muriana FJ, Osada, Panagiotakos DB, Paniagua JA, Pérez-Martínez P, Perona J, Peinado MA, Pineda-Priego M, Poulsen HE, Quiles JL, Ramírez-Tortosa MC, Ruano J, Serra-Majem L, Solá R, Solanas M, Solfrizzi V, de la Torre-Fornell R, Trichopoulou A, Uceda M, Villalba-Montoro JM, Villar-Ortiz JR, Visioli F, Yiannakouris N: Olive oil and health: summary of the II international conference on olive oil and health consensus report, Jaén and Córdoba (Spain) 2008. Nutr Metab Cardiovasc Dis 2010, 20(4):284-294.
81. Fitó M, Gimeno E, Covas MI, Miró E, López-Sabater M, Farré M, de la Torre R, Marrugat J: Postprandial and short-term effects of dietary virgin olive oil on oxidant/antioxidant status. Lipids 2002, 37(3):245-251.
82. Fitó M, Cladellas M, de la Torre R, Martí J, Alcántara M, Pujadas-Bastardes M, Marrugat J, Bruguera J, López-Sabater MC, Vila J, Covas MI: Antioxidant effect of virgin olive oil in patients with stable coronary heart disease: a randomized, crossover, controlled, clinical trial. Atherosclerosis 2005, 181(1):149-158.
83. Marrugat J, Covas MI, Fitó M, Schröder H, Miró-Casas E, Gimeno E, López-Sabater MC, de la Torre F, Farré M: Effects of differing phenolic content in dietary olive oils on lipids and LDL oxidation-a randomized controlled trial. Eur J Nutr 2004, 43(3):140-147.
84. Weinbrenner T, Fitó M, de la Torre R, Sáez GT, Rijken P, Tormos C, Coolen S, Farré M, Abanades S, Schröder H, Marrugat J, Covas MI: Olive oils high in phenolic compounds modulate oxidative/ antioxidative status in men. J Nutr 2004, 134(9):2314-2321.
85. O'Keefe JH, Bell DS: Postprandial hyperglycemia/hyperlipidemia (postprandial dysmetabolism) is a cardiovascular risk factor. Am J Cardiol 2007, 100(5):899-904.
86. Sies H, Stahl W, Sevanian A: Nutritional, dietary and postprandial oxidative stress. J Nutr 2005, 135(5):969-972.
87. Dennis K, Shimamoto T: Production of malonyldialdehyde from squalene, a major skin surface lipid, during UV irradiation. Photochem Photobiol 1989, 49; 711-719.
88. Strandberg TE, Tilvis RS, Miettinen TA: Metabolic variables of cholesterol during squalene feeding in humans: comparison with cholestyramine treatment. J Lipid Res 1990, 31:1637-1643.
89. Granados-Principal S, Quiles JL, Ramirez-Tortosa CL, Ochoa-Herrera J, Pérez-López P, Pulido-Moran M, Ramírez-Tortosa MC: Squalene ameliorates atherosclerotic lesions through the reduction of CD36 scavenger receptor expression in macrophages. Mol Nutr Food Res 2012, 56(5):733-740.
90. Cabello-Moruno R, Perona JS, Ruiz-Gutierrez V: Influence of minor components of olive oils on the composition and size of TRLs and on macrophage receptors involved in foam cell formation. Biochem Soc Trans 2007, 35(Pt 3):470-471.
91. Lou-Bonafonte JM, Arnal C, Navarro MA, Osada J: Efficacy of bioactive compounds from extra virgin olive oil to modulate atherosclerosis development. Mol Nutr Food Res 2012, 56(7):1043-1057.
92. Graham VS, Lawson C, Wheeler-Jones CP, Perona JS, Ruiz-Gutiérrez V, Botham KM: Triacylglycerol-rich lipoproteins derived from healthy donors fed different olive oils modulate cytokine secretion and cyclooxygenase-2 expression in macrophages: the potential role of oleanolic acid. Eur J Nutr 2012, 51(3):301-309.
93. Giustarini D, Dalle-Donne I, Tsikas D, Rossi R: Oxidative stress and human diseases: Origin, link, measurement, mechanisms, and biomarkers. Crit Rev Clin Lab Sci 2009, 46(5-6):241-281.
94. De Stéfani E, Deneo-Pellegrini H, Boffetta P, Ronco AL, Aune D, Acosta G, Mendilaharsu M, Brennan P, Ferro G: Dietary Patterns and Risk of Cancer: A Factor Analysis in Uruguay. Int J Cancer 2009, 124(6):1391-1397.
95. De Stéfani E, Ronco AL, Boffetta P, Deneo-Pellegrini H, Correa P, Acosta G, Mendilaharsu M: Nutrient-derived dietary patterns and risk of colorectal cancer: a factor analysis in Uruguay. Asian Pac J Cancer Prev 2012, 13(1):231-235.
96. Roche HM: Dietary lipids and gene expression. Biochem Soc Trans 2004, 32(Pt 6):999-1002.
97. Müller M, Kersten S: Nutrigenomics: goals and strategies. Nat Rev Genet 2003, 4(4):315-322.
98. Santangelo C, Varì R, Scazzocchio B, Di Benedetto R, Filesi C, Masella R: Polyphenols, intracellular signalling and inflammation. Ann Ist Super Sanita 2007, 43(4):394-405.
99. Guillén N, Acín S, Navarro MA, Surra JC, Amal C, Lou-Bonafonte JM, Muniesa P, Martínez-Gracia MV, Osada J: Knowledge of the biological actions of extra virgin olive oil gained from mice lacking apolipoprotein E. Rev Esp Cardiol 2009, 62(3):294-304.